http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009063493-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9276437a3444db5cbba1d0d800ff6ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cdb1ef9fe36ae01e3729156a7103103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33f143df02f6b222f3d5a7dea6478e51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1bc0840a4eb5191f87a09be92d5ce5b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
filingDate 2008-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d241a09fb2d2d45776c77442c82472e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3316d5abacff1395cb9c293bf4340b77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16896e8159d788ba54e53bb49d710161
publicationDate 2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009063493-A3
titleOfInvention Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
abstract The present invention relates to topical compositions comprising combination of mometasone furoate and fusidic acid. The present invention also relates to use of topical combinations of mometasone furoate and fusidic acid for prevention and treatment of dermal infections. The present invention also relates to topical compositions comprising Halobetasol propionate and fusidic acid and their use for prevention and treatment of dermal conditions.
priorityDate 2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007077029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03097070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007087806-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007014563-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0752247-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53911549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54075101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135742662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135769229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135855390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56982531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136160078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22852804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129257918

Total number of triples: 52.